Entrada Therapeutics, Inc. ( TRDA) - Stock Earnings
TRDA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -44.1 million USD | 1.6 million USD |
| 2025Q4 | -39.2 million USD | 1.3 million USD |
| 2026Q1 | -39.7 million USD | 875000 USD |
TRDA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -6.7 million USD | 129.0 million USD |
| 2024 | 65.6 million USD | 210.8 million USD |
| 2025 | -143.8 million USD | 25.4 million USD |
| 2026 Est. | — | — |
TRDA
Price: $6.72
52 week price:
Earnings Per Share: -4.00 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 22900
Market Capitalization: 268.4 million